Literature DB >> 16273381

Radiation risk estimates after radiotherapy: application of the organ equivalent dose concept to plateau dose-response relationships.

Uwe Schneider1, Barbara Kaser-Hotz.   

Abstract

Estimates of secondary cancer risk after radiotherapy are becoming more important for comparative treatment planning. Modern treatment planning systems provide accurate three-dimensional (3D) dose distributions for each individual patient. The dose distributions can be converted into organ equivalent doses to describe radiation-induced cancer after radiotherapy (OED(rad-ther)) in the irradiated organs. The OED(rad-ther) concept assumes that any two dose distributions in an organ are equivalent if they cause the same radiation-induced cancer risk. In this work, this concept is applied to dose-response relationships, which are leveling off at high dose. The organ-dependent operational parameter of this dose-response relationship was estimated by analyzing secondary cancer incidence data of patients with Hodgkin's disease. The dose distributions of a typical radiotherapy treatment plan for treating Hodgkin's disease was reconstructed. Dose distributions were calculated in individual organs from which cancer incidence data were available. The model parameter was obtained by comparing dose and cancer incidence rates for the individual organs.

Entities:  

Mesh:

Year:  2005        PMID: 16273381     DOI: 10.1007/s00411-005-0016-1

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  12 in total

Review 1.  Radiation therapy in the management of Hodgkin's disease.

Authors:  R T Hoppe
Journal:  Semin Oncol       Date:  1990-12       Impact factor: 4.929

2.  Dose-response relationship for radiation-induced cancer--decrease or plateau at high dose: in regard to Davis (Int J Radiat Oncol Biol Phys 2004;59:916).

Authors:  Uwe Schneider
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-01-01       Impact factor: 7.038

3.  A simple dose-response relationship for modeling secondary cancer incidence after radiotherapy.

Authors:  Uwe Schneider; Barbara Kaser-Hotz
Journal:  Z Med Phys       Date:  2005       Impact factor: 4.820

4.  Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose.

Authors:  Uwe Schneider; Daniel Zwahlen; Dieter Ross; Barbara Kaser-Hotz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-04-01       Impact factor: 7.038

5.  Computerized three-dimensional segmented human anatomy.

Authors:  I G Zubal; C R Harrell; E O Smith; Z Rattner; G Gindi; P B Hoffer
Journal:  Med Phys       Date:  1994-02       Impact factor: 4.071

6.  Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis.

Authors:  P M Mauch; L A Kalish; M Kadin; C N Coleman; R Osteen; S Hellman
Journal:  Cancer       Date:  1993-03-15       Impact factor: 6.860

7.  Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997.

Authors:  Dale L Preston; Yukiko Shimizu; Donald A Pierce; Akihiko Suyama; Kiyohiko Mabuchi
Journal:  Radiat Res       Date:  2003-10       Impact factor: 2.841

Review 8.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT.

Authors:  Eric J Hall; Cheng-Shie Wuu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-05-01       Impact factor: 7.038

Review 9.  Henry S. Kaplan Distinguished Scientist Award 2003. The crooked shall be made straight; dose-response relationships for carcinogenesis.

Authors:  E J Hall
Journal:  Int J Radiat Biol       Date:  2004-05       Impact factor: 2.694

Review 10.  Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.

Authors:  D E Thompson; K Mabuchi; E Ron; M Soda; M Tokunaga; S Ochikubo; S Sugimoto; T Ikeda; M Terasaki; S Izumi
Journal:  Radiat Res       Date:  1994-02       Impact factor: 2.841

View more
  30 in total

1.  Agreement between gamma passing rates using computed tomography in radiotherapy and secondary cancer risk prediction from more advanced dose calculated models.

Authors:  Abdulhamid Chaikh; Jacques Balosso
Journal:  Quant Imaging Med Surg       Date:  2017-06

2.  Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.

Authors:  Shunsuke Suzuki; Takahiro Kato; Masao Murakami
Journal:  J Radiat Res       Date:  2021-03-10       Impact factor: 2.724

Review 3.  Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy.

Authors:  Harald Paganetti
Journal:  Health Phys       Date:  2012-11       Impact factor: 1.316

4.  Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy.

Authors:  Uwe Schneider; Linda Walsh
Journal:  Radiat Environ Biophys       Date:  2007-12-21       Impact factor: 1.925

5.  Second cancers after fractionated radiotherapy: stochastic population dynamics effects.

Authors:  Rainer K Sachs; Igor Shuryak; David Brenner; Hatim Fakir; Lynn Hlatky; Philip Hahnfeldt
Journal:  J Theor Biol       Date:  2007-08-12       Impact factor: 2.691

6.  Quasi-IMAT technique and secondary cancer risk in prostate cancer.

Authors:  Judith Alvarez Moret; Oliver Koelbl; Ludwig Bogner
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

Review 7.  A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction.

Authors:  X George Xu; Bryan Bednarz; Harald Paganetti
Journal:  Phys Med Biol       Date:  2008-06-09       Impact factor: 3.609

8.  Is the risk for secondary cancers after proton therapy enhanced distal to the Planning Target Volume? A two-case report with possible explanations.

Authors:  Uwe Schneider; Anthony Lomax; Beat Hauser; Barbara Kaser-Hotz
Journal:  Radiat Environ Biophys       Date:  2006-02-07       Impact factor: 1.925

9.  Estimation of radiation-induced second cancer risk associated with the institutional field matching craniospinal irradiation technique: A comparative treatment planning study.

Authors:  Hemalatha Athiyaman; Athiyaman Mayilvaganan; Arun Chougule; Mary Joan; Harvinder Singh Kumar
Journal:  Rep Pract Oncol Radiother       Date:  2019-07-08

10.  Exposure of remote organs and associated cancer risks from tangential and multi-field breast cancer radiotherapy.

Authors:  C Simonetto; H Rennau; J Remmele; S Sebb; P Kundrát; M Eidemüller; U Wolf; G Hildebrandt
Journal:  Strahlenther Onkol       Date:  2018-10-22       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.